hotspot
Previous article:
Walensky prepares to leave CDC — and Congress — behind
Next article: Why Eli Lilly’s earnings didn’t quite live up to the hype
Next article: Why Eli Lilly’s earnings didn’t quite live up to the hype
hotspot
explore
-
Websites selling Wegovy, Zepbound ingredients targeted by FDA
2025-10-02 20:48 -
Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
2025-10-02 19:50 -
Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
2025-10-02 19:50 -
Readout LOUD podcast: ALS dilemma, first MASH drug, and more
2025-10-02 19:43 -
Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study
2025-10-02 19:22 -
HHS secretary Becerra pressed on Change HealthCare cyberattack
2025-10-02 19:12